Clinical Trial Update: A Molecule Basic Study of Early Warning for New Pathogenic Risk of Ankylosing Spondylitis [NA]

View source ↗

Summary

The document reports the completion of a basic molecular study aimed at early warning of new pathogenic risk related to Ankylosing Spondylitis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ankylosing Spondylitis

Snippet

Sponsor: Sun Yat-sen University | Conditions: Ankylosing Spondylitis | NA | Status: COMPLETED